Manage Your Liver
Q:

Hep C News: Only heading in a new direction of treatment will help prevent deaths

Hep C News: Only heading in a new direction of treatment will help prevent deaths
A:

Recent data released by the Centre for Disease Control and Prevention (CDC) showed that the deaths associated with hepatitis C reached an all-time high of 19,659 in 2014. Since 2013, the annual hepatitis C-related mortality surpassed the total combined number of deaths from 60 other infectious diseases. [1]

 

Although the effectiveness of  the recently introduced hepatitis C antiviral treatment (DAA) is higher than previous drugs, this new treatment does not directly reduce liver damage nor improve liver health. [2] Together with the data released by CDC, it is suggested that the DAA treatments are not able to lower the number of deaths related to hepatitis C.

 

The only function of antiviral drugs is to eliminate the hepatitis virus in the human body, thus, to regain liver health, the liver must recover itself using its unique self-repairing ability. However using drugs actually causes further damage to the liver as the drug itself contains toxicity. A recent published paper has found that using DAA treatment might have an impact on the immune system as there is a sudden change of viral count, thus dramatically increasing the risk of liver cancer. [3] The number of related deaths caused by hepatitis C is continuously increasing; this is a clear indication that it is time to reconsider current treatment direction.

 

From the patients’ point of view, the primary objective of treatment should be to ensure normal liver function (ALT level), to reduce and prevent liver fibrosis, and to improve the quality of daily life. Only by successfully carrying out these objectives can one ensure long term liver health protection, reduce the likelihood of severe liver diseases and lower the risk of deaths caused by liver inflammation related diseases.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
With thousands of supplements in the market, and little regulations on supplements, finding a suitable one is difficult enough, let alone finding a SAFE one!   Here we will look at 5 things that you can look for when buying or using supplements, it can help you to avoid risky products and limited the chance of using something unsafe:   1. Look for registrations In some country, there are registration systems on suppl
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us